AUAUniversity

PARPi: Management of Adverse Events (2024) CME Available: https://auau.auanet.org/node/39609 Release Date: January, 2024 Expiration Date: January, 2025 LEARNING OBJECTIVES: 1. Identify approved PARPi for prostate cancer and patients who may benefit from PARPi based therapy. 2. Evaluate available clinical safety and efficacy data for PARPi. 3. Describe indications and contraindications for PARPi in...

AUA2023 Journal of Urology Lecture: Surgery Harms Surgeons. What can we do? Speaker: Dr. Kevin Turner

AUA2023 Ramon Guiteras Lecture: The Complicated Decisions Required to Eliminate Never Events Speaker: Dr Louis Kavoussi, Smith Institute For Urology.

AUA2023 John Duckett Memorial Lecture: Innovation by Necessity: Improving Urodynamics for Children with Spina Bifida Speaker: Dr. Johnathan Routh, Chief of Children's Surgery, Duke University School of Medicine.

AUA2023 John K. Lattimer Lecture: Innovation in Urology: From a Seminal “Why” to a Functional “How” Speaker: Dr. Ralph Clayman, Distinguished Professor / Endowed Chair in Endourology, University of California, Irvine.

The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Adjuvant Therapies for High-Risk Non-Metastatic Kidney Cancer CME Available: https://auau.auanet.org/node/39542 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES: At the conclusion of this activity, participants will be able to: 1. Identify the rationale behind using adjuvant therapies in high-risk n...

The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: The Latest Breakthroughs in Immunotherapy for GU Cancers CME Available: https://auau.auanet.org/node/39543 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES: At the conclusion of this activity, participants will be able to: 1. Identify the newest immunotherapy drugs approved for prostate, bladder, an...

The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Germline Testing and Novel Approaches to Targeting Genetic Mutations in Prostate Cancer CME Available: auau.auanet.org/node/39487 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Identify the indications for germline testing in pro...

The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Novel Imaging for Genitourinary Cancers - Diagnostics and Theranostics CME Available: https://auau.auanet.org/node/39411 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Review the latest clinical trials investigating the use of PE...

The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Early Detection of Prostate Cancer: AUA/SUO Guideline (2023) CME Available: https://auau.auanet.org/node/39410 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Discuss the potential benefits, limitations, and controversies associat...

The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Treatment Paradigms for Intermediate and High-Risk Non-Muscle Invasive Bladder Cancer CME Available: https://auau.auanet.org/node/39374 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES: At the conclusion of this activity, participants will be able to: 1. Describe the importance of individualized tre...

PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test (2023) CME Available: https://auau.auanet.org/node/39603 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES: At the conclusion of this activity, the learner will be able to: 1. Review recommended criteria for genetic testing of prostate cancer patients, currently available gene panels, and optio...

Infectious Complications Following Prostate Biopsy: Strategies for Reducing Infections and Reducing Health Care Costs CME Available: https://auau.auanet.org/node/39485 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Describe health care costs associated with prostate biopsy infections. 2. Identify...

The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Germline Testing in GU Cancers – How I Do It CME Available: https://auau.auanet.org/node/39544 Release Date: December, 2023 Expiration Date: December, 2024 ACKNOWLEDGEMENTS: Support provided by independent educational grants from:  AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC  Lantheus Medical...

The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Treatment Intensification for Advanced Prostate Cancer CME Available: https://auau.auanet.org/node/39486 Release Date: November, 2023 Expiration Date: November, 2024 LEARNING OBJECTIVES: At the conclusion of these activities, participants will be able to: 1. Identify the latest developments in hormone therapy for advanced prostate...

PARPi: Precision Medicine in Advanced Prostate Cancer (2023) CME Available: https://auau.auanet.org/node/39597 Release Date: November, 2023 Expiration Date: November, 2024 At the conclusion of this activity, the learner will be able to: 1. Describe the mechanism of action of PARP inhibitors and the differences among drugs in this class. 2. Describe the role of PARPi treatment alone and in combinat...

Prostate Cancer Treatment Intensification Moderator: Dr. Jay D. Raman Guest: Dr. Michael S. Cookson Acknowledgement: This podcast was funded by and in collaboration with AZ. All opinions are that of the faculty and do not necessarily reflect those of AstraZeneca. Release Date: 11/8/2023 Expiration Date: 11/8/2024

Update Series (2023) Lesson 33: A Critical Appraisal of the 2021 AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction Now in its 42nd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most pro...

Disparities in Care and Barriers to Access for Patients with Advanced Prostate Cancer CME Available: https://auau.auanet.org/node/39088 Release Date: October, 2023 Expiration Date: October, 2024 At the conclusion of these activities, participants will be able to: 1. Recognize current patterns of use for systemic therapies in patients with advanced prostate cancer. 2. Identify disparities in access...

Systemic Therapies for Advanced Prostate Cancer – Short and Long-Term Side Effects CME Available: https://auau.auanet.org/node/39087 Release Date: October, 2023 Expiration Date: October, 2024 At the conclusion of these activities, participants will be able to: 1. Characterize current treatment paradigm for systemic therapies in managing advanced prostate cancer including doublet and triple therapy...

Genetic Testing and Stone Disease Co-host: Kyle Wood, MD Population analysis demonstrated that genetic conditions resulting in stone disease are magnitudes higher than those seen in clinical cohorts, suggesting underdiagnosis. Urologist play a unique role as we often times have many touch points with these patient given their presentation for stone disease. With the advancement of treatments, spec...

Advances in ADT Part II: A Guide for Urologists CME Available: https://auau.auanet.org/node/39385 Release Date: October, 2023 Expiration Date: October, 2024 LEARNING OBJECTIVES After participating in this educational activity, participants will be able to: 1. Recognize and characterize different disease states for advance prostate cancer including M0 HSPC, M1 HSPC, M0 CRPC, and M1 CRPC. 2. Discuss...

Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice CME Available: https://auau.auanet.org/node/39292 Release Date: September, 2023 Expiration Date: September, 2024 After participating in this educational activity, participants will be able to: 1. Cite recommendations within the newly amended AUA/SUO Advanced Prostate Cancer Guideline. 2. Assess the impact of newly approv...

AUA2023 Medical Student Forum

AUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide CME Available: https://auau.auanet.org/node/38322 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc.